NovoCure(DE:038)
€10.66+0.32 (+3.10%)
DE:038
NovoCure earnings date
€10.66
At close:+0.32 (+3.10%)
NovoCure (038) Q2 2021 Earnings Report
4 Followers
DE:038 Q2 2021 EPS Results
- Actual EPS
- -EUR 0.13
- Consensus EPS
- EUR 0.01
- Beat/Miss
- Missed by -EUR 0.13
- One Year Ago EPS
- EUR 0.02
DE:038 Q2 2021 Revenue Results
- Actual Revenue
- EUR 120.69M
- Expected Revenue
- EUR 127.91M
- Beat/Miss
- Missed by -EUR 7.22M
- YoY Revenue Growth
- +15.18%
Earnings Announcement Details
- Quarter
- Q2 2021
- Date
- 07/29/2021
- Time
- Before Open
- Conference Call
- Thursday, July 29, 2021
DE:038 Upcoming Earnings
NovoCure's next earnings date is estimated for February 25, 2027, based on past reporting schedules.
Q2 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:038 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 25, 2027 | 2026 (Q4) | -0.19- | -0.2 | ― | ― |
| Oct 29, 2026 | 2026 (Q3) | -0.21-0.08 | -0.3 | 72.73% (+0.22) | |
| Jul 23, 2026 | 2026 (Q2) | -0.30-0.12 | -0.33 | 63.89% (+0.21) | |
| Apr 30, 2026 | 2026 (Q1) | -0.46-0.56 | -0.28 | -100.00% (-0.28) | |
| Feb 26, 2026 | 2025 (Q4) | -0.37-0.20 | -0.55 | 63.93% (+0.35) | |
| Oct 30, 2025 | 2025 (Q3) | -0.38-0.30 | -0.25 | -17.86% (-0.05) | |
| Jul 24, 2025 | 2025 (Q2) | -0.35-0.33 | -0.28 | -16.13% (-0.05) | |
| Apr 24, 2025 | 2025 (Q1) | -0.42-0.28 | -0.33 | 13.89% (+0.05) | |
| Feb 27, 2025 | 2024 (Q4) | -0.31-0.55 | -0.41 | -35.56% (-0.14) | |
| Oct 30, 2024 | 2024 (Q3) | -0.30-0.25 | -0.42 | 39.13% (+0.16) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
